Store
The U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing, 2nd Edition
Publication Date: May 25, 2022
Tags: Diagnostic Instruments, Lab Equipment, Patient Monitoring and Telehealth, Personalized Medicine
Pages: 100
SKU: 22-712
Direct to consumer laboratory testing is also known as patient-ordered laboratory testing. A variety of tests are now available for direct to consumer testing. The growing market for direct-to-consumer laboratory testing may promote awareness of health issues and genetic diseases, which will allow patients to take a more proactive role in their healthcare. With advances in technology, the completion of the sequencing of the human genome and the pressures of the pandemic, direct to consumer lab testing is becoming increasingly popular. Still, clinical laboratories are an essential part of the health industry. It is estimated that the vast majority of physician’s diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons.
Several trends are continuing to shape the direct-to-consumer laboratory testing market including the growing demand for early disease detection and diagnosis, personalized medicine, importance of disease monitoring, consumer acceptance and expanded technologies. This report, The U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing, 2nd Edition, examines these and other essential market trends.
Report Highlights:
- Market Dynamics:
- Overview of the increasing popularity of direct-to-consumer laboratory testing, also known as patient-ordered laboratory testing.
- Examination of how technological advances, the completion of the human genome sequencing, and the pandemic have accelerated the adoption of DTC lab testing.
- Insights into the essential role clinical laboratories play in diagnosing diseases, evaluating disease progression, monitoring drug treatments, and determining individual therapies.
- Consumer Trends:
- Analysis of the growing demand for early disease detection and diagnosis, personalized medicine, and disease monitoring.
- Discussion on consumer acceptance and the impact of expanded technologies on the DTC lab testing market.
Scope and Methodology:
- Market Segmentation:
- Detailed exploration of demographics, aging population, growing incidence of disease, and the regulatory environment.
- Analysis of consumer-driven healthcare, the emphasis on preventative healthcare, and developments in personalized medicine.
- Coverage of trends in mobile devices, informed consent, payment structures, and sales by distribution channel.
- Comprehensive Coverage:
- Issues and Trends:
- Impact of telehealth on DTC testing.
- Profiles of leading companies such as 23andMe, Any Lab Test Now, Color Genomics, Direct Laboratory Services, EasyDNA, Everlywell, Laboratory Corporation of America, MyMedLab, Ombre Gut Health (formerly Thryve), Quest Diagnostics, and Request A Test.
- Leading Participants: Insights into large diagnostic companies and their involvement in the DTC market.
- Issues and Trends:
Competitive Landscape:
- Company Coverage:
- Analysis of key players in the DTC laboratory testing market, including their strategies and market positions.
- Overview of the competitive environment, highlighting the role of major diagnostic companies and their approaches to the DTC market.
Report Scope:
The scope of this report covers direct-to-consumer (DTC) laboratory testing, excluding point-of-care and over-the-counter testing where a laboratory is not required. The geographical focus is the United States, with a base year of 2021 and forecasts for 2022-2026.
Table: U.S. DTC Laboratory Testing Market 2021-2026 (in millions $)
| Year | Revenues | Percent Change |
| 2021 | $XX Million | XX% |
| 2022 | $XX Million | XX% |
| 2023 | $XX Million | XX% |
| 2024 | $XX Million | XX% |
| 2025 | $XX Million | XX% |
| 2026 | $XX Million | XX% |
| Compound Annual Growth Rate | ||
| 2021-2023 | XX% | |
| 2023-2026 | XX% | |
| 2021-2026 | XX% | |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Overview
Size and Growth of the Market
- Table 1-1: U.S. DTC Laboratory Testing Market 2021-2026 (in millions % at manufacturer level)
- Figure 1-1: U.S. DTC Laboratory Testing Market, 2021-2026
Scope and Methodology
Key Issues and Trends Affecting the Market
Leading Market Participants
Conclusions
Chapter 2: Introduction
The U.S. Laboratory Service Industry
Growth of the DTC Testing Market
U.S. Laboratory Industry Structure
- Figure 2-1: Growth in Clinical Laboratories, 1997-2021
CLIA Laboratory Registration, Laboratories by Type
- Figure 2-2: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type of Facility, 2022
- Table 2-1: CLIA Registered Laboratories by Type of Facility (Exempt/Non-exempt Combined) May 2022
Direct-to-Consumer Testing
- Table 2-2: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and LabCorp On Demand) 2022* (in US $)
DTC in Genetic Testing
New Opportunities in Direct-to-Consumer Testing Outlets
Dialysis Clinics
Hospitals
- Table 2-3: U.S. Hospital Types
Regulation in the Laboratory Industry
Certificate of Waiver
- Table 2-4: Selected CLIA Waived Laboratory Tests
Laboratory Developed Tests
State-by-State Evaluations
- Table 2-5: State Regulation in DTC Laboratory Testing
Testing and Services
- Table 2-6: DTC Tests with FDA Marketing Authorization
Chapter 3: Direct-to-Consumer Routine Clinical Laboratory Testing
Routine Testing
Blood Cell Count
- Table 3-1: Laboratory Reference Parameters for CBC
Cholesterol Level Testing
- Table 3-2: High Cholesterol Risk Categories
Diabetes Testing
HIV Testing
Pregnancy Testing
- Table 3-3: HCG Levels in Pregnant Women by Days Past Ovulation
Substance Abuse Testing
- Table 3-4: Substance Detection Periods by Test Method
Urinalysis
- Table 3-5: Normal Reference Levels in a Medical Urinalysis
COVID-19
Saliva Testing
DTC Routine Clinical Laboratory Market Drivers and Barriers
- Table 3-6 : DTC Routine Clinical Laboratory Testing : Market Drivers and Barriers
Market Size and Growth
- Table 3-7: US DTC Routine Laboratory Testing Market 2021-2026 (in millions % at manufacturer level)
- Figure 3-1: U.S. Direct-to-Consumer Routine Clinical Testing Market Analysis: 2021-2026
- Figure 3-2: U.S. Direct-to-Consumer Routine Clinical Testing Compared to COVID-19 Testing, 2021
Competitive Landscape
- Figure 3-3: Global Direct to Consumer Routine Clinical Testing Market, Market Share of Leading Suppliers by % 2021
Chapter 4: Direct-to Consumer Genetic Laboratory Testing Market
Genetic Research
Growth of DTC Genetic Testing Market
Types of DTC Genetic Testing
Evolution of DTC Genetic Testing
DTC Genetic Testing Business Model
Market Constraints
DTC Genetic Laboratory Testing Market Drivers and Barriers
- Table 4-1: DTC Genetic Laboratory Testing, Market Drivers and Barriers
Market Size and Growth
- Table 4-2: U.S. DTC Genetic Laboratory Testing Market 2021-2026 (in millions % at manufacturer level)
- Figure 4-1: U.S. Direct-to-Consumer Genetic Laboratory Testing Market Analysis 2021-2026
Competitive Landscape
- Figure 4-2: U.S. Direct to Consumer Genetic Testing Market, Market Share of Leading Suppliers by % 2021
Chapter 5: Industry Drivers and Barriers
Overview
- Table 5-1: DTC Laboratory Testing Market Drivers and Barriers
Issues and Trends Driving the Direct-to-Consumer Market
Consumer Driven Healthcare
Affordability and Accessibility
Privacy
Aging Population
- Figure 5-1: US Population Trends, 65 Years and Older Percent of Total Population 2000-2050
Increase in Chronic Disease
- Figure 5-2: Prevalence of Disease, 2000, 2015 and Projected 2030
Emphasis on Preventative Healthcare
Regulatory Environment
Regulatory Pathway
Accuracy
Informed Consent
Payment Structure for Direct-to-Consumer Laboratory Testing
Patient Direct Pay
- Table 5-2: Select Tests and Prices by Laboratory Service Providers 2022 (in US $)
Flexible Spending Accounts and Health Savings Accounts
Sales by Distribution Channel
- Figure 5-3: Global DTC Laboratory Testing by Channel Type 2021 by Percent
Mobile Devices
Large Diagnostic Companies and DTC
Telehealth and DTC Testing
Chapter 6: Company Profiles
23andMe, Inc
- Table 6-1: 23andMe Corporate Summary
Company Overview
Products
Company Financials
- Table 6-1: 23andMe Revenue (2019-2021) ($ millions)
Any Lab Test Now, Inc.
- Table 6-2: Any Lab Test Now Corporate Summary
Company Overview
Products
Color Genomics, Inc
- Table 6-3: Color Genomics Corporate Summary
Company Overview
Products
Direct Laboratory Services, LLC
- Table 6-4: Direct Laboratory Services Corporate Summary
Company Overview
Products
EasyDNA
- Table 6-5: EasyDNA Corporate Summary
Company Overview
Products
Everlywell
- Table 6-6: Everlywell Corporate Summary
Company Overview
Products
Laboratory Corporation of America
- Table 6-7: Laboratory Corporation of America Corporate Summary
Company Overview
Products
Company Financials
- Table 6-8: LabCorp Revenue (2019-2021) ($ millions)
MyMedLab, Inc.
- Table 6-9: MyMedLab Corporate Summary
Company Overview
Products
Medichecks.com Ltd.
- Table 6-10: Medichecks Corporate Summary
Company Overview
Products
Myriad Genetics, Inc.
- Table 6-11: Myriad Genetics Corporate Summary
Company Overview
Products
Company Financials
- Table 6-12: Myriad Diagnostics Revenue (2019-2021) ($ millions)
Ombre Gut Health (formerly Thryve)
- Table 6-13: Ombre Corporate Summary
Company Overview
Products
Quest Diagnostics, Inc.
- Table 6-14: Quest Diagnostics Corporate Summary
Company Overview
Products
Company Financials
- Table 6-15: Quest Revenue (2019-2021) ($ millions)
Request A Test, Ltd.
- Table 6-16: Request A Test Corporate Summary
Company Overview
Products
Related products
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
$3,000.00 – $4,500.00
Hematology and Coagulation Markets, 2023
April 5, 2023
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing…
$3,000.00 – $4,500.00
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
$4,000.00 – $6,000.00
